date,title,source
Oct-17-18,Aclaris Announces Pricing of Public Offering of Common Stock,GlobeNewswire
Oct-17-18,Aclaris Announces Proposed Public Offering of Common Stock,GlobeNewswire
Oct-17-18,"The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise",Benzinga
Oct-19-18,Aclaris plans $92.9M public stock offering,American City Business Journals
Oct-22-18,Aclaris Announces Closing of Public Offering of Common Stock,GlobeNewswire
Oct-23-18,One Thing To Remember About The Aclaris Therapeutics Inc (NASDAQ:ACRS) Share Price,Simply Wall St.
Oct-29-18,"Aclaris Therapeutics to Announce Third Quarter 2018 Financial Results on November 6, 2018",GlobeNewswire
Oct-30-18,Analysts Estimate Aclaris Therapeutics (ACRS) to Report a Decline in Earnings: What to Look Out for,Zacks
Nov-06-18,"Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-06-18,Aclaris: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Aclaris Therapeutics Reports Third Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments,GlobeNewswire
Nov-07-18,Edited Transcript of ACRS earnings conference call or presentation 6-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-16-18,Edited Transcript of ACRS earnings conference call or presentation 6-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-27-18,Aclaris Therapeutics (ACRS) Enters Oversold Territory,Zacks
Nov-27-18,"Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-28-18,Aclaris Therapeutics to Attend Upcoming Investor Conferences,GlobeNewswire
Dec-17-18,Aclaris Therapeutics Provides Update on Oral and Topical JAK 1/3 Inhibitor Clinical Trials,GlobeNewswire
